Essex Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-22,636
| Closed | -$1.71M | – | 439 |
|
|
2018
Q2 | $1.71M | Buy |
22,636
+2
| +0% | +$151 | 0.21% | 145 |
|
|
2018
Q1 | $1.19M | Sell |
22,634
-2,301
| -9% | -$121K | 0.16% | 187 |
|
|
2017
Q4 | $1.33M | Buy |
24,935
+670
| +3% | +$35.8K | 0.18% | 183 |
|
|
2017
Q3 | $1.45M | Sell |
24,265
-3,096
| -11% | -$185K | 0.2% | 171 |
|
|
2017
Q2 | $2.16M | Buy |
27,361
+5,367
| +24% | +$423K | 0.31% | 107 |
|
|
2017
Q1 | $1.82M | Buy |
21,994
+2,391
| +12% | +$198K | 0.29% | 102 |
|
|
2016
Q4 | $1.56M | Buy |
19,603
+5,082
| +35% | +$403K | 0.26% | 106 |
|
|
2016
Q3 | $1.02M | Buy |
+14,521
| New | +$1.02M | 0.16% | 160 |
|